Declining hepatitis A seroprevalence: A global review and analysis

Epidemiology and Infection

Volumn 132, Issue 6, 2004, Pages 1005-1022

  Jacobsen, K H ^a   Koopman, J S ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

AFRICA; AGE DISTRIBUTION; ASIAN; AUSTRALIA; CANADA; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG COST; EDUCATION; EUROPE; FOOD CONTAMINATION; HEALTH PROGRAM; HEPATITIS A; HEPATITIS A VIRUS; HOUSEHOLD; HUMAN; HYGIENE; IMMUNITY; INCOME; INFECTION SENSITIVITY; JAPAN; MIDDLE EAST; NEW ZEALAND; REVIEW; SANITATION; SEROPREVALENCE; SOCIAL STATUS; SOUTH AND CENTRAL AMERICA; UNITED STATES; VACCINATION; VIRUS TRANSMISSION; WATER CONTAMINATION; WATER QUALITY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; HYGIENE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RISK FACTORS; SANITATION; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX; SOCIAL CLASS; WATER SUPPLY; WORLD HEALTH;

EID: 10444284218     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268804002857     Document Type: Review

References (271)

1. Abdool Karim SS, Coutsoudis A. Sero-epidemiology of hepatitis A in black South African children. S Afr Med J 1993; 83: 748-749.
2. Ajdukiewicz A, Mosely JW. Hepatitis-A-virus exposure in the Gambia. Lancet 1979; 2: 966.
3. Ayoola EA. Antibody to hepatitis A virus in healthy Nigerians. J Natl Med Assoc 1982; 74: 465-468.
4. Barin F, Denis F, Chotard J, et al. Early asymptomatic hepatitis A in Senegalese children. Lancet 1980; 1: 212-213.
5. Bile K, Aceti A, Hagi MA, et al. Primary hepatitis A virus infection in developing countries: decline of maternal antibodies and time of infection. Boll Ist Sieroterapico Milan 1986; 65: 464-466.
6. Crocchiolo PR, Caredda F, D'Arminio Monforte A, et al. The aetiology of acute hepatitis in Zimbabwe. Trans R Soc Trop Med Hyg 1984; 78: 514-518.
7. Hodges M, Sanders E, Aitken C. Seroprevalence of hepatitis markers: HAV, HBV, HCV, and HEV amongst primary school children in Freetown, Sierra Leone. West Afr J Med 1998; 17: 36-37.
8. Fox E, Abbatte EA, Said-Salah, Constantine NT, Wassef HH, Woody JN. Viral hepatitis markers in Djibouti: an epidemiological survey. Trans R Soc Trop Med Hyg 1988; 82: 750-752.
9. Joubert JJ, Prozesky OW, Lourens JGH, et al. Prevalence of hepatitis virus and some arbovirus infections in Kavango, northern SWA/Namibia. S Afr Med J 1985; 67: 500-502.
10. Martin DJ, Blackburn NK, Johnson S, McAnerney JM. The current epidemiology of hepatitis A infection in South Africa: implications for vaccination. Trans R Soc Trop Med Hyg 1994; 88: 288-291.
11. Miller WC, Shao JF, Weaver DJ, Shimokura GH, Paul DA, Lallinger GJ. Seroprevalence of viral hepatitis in Tanzanian adults. Trop Med Int Health 1998; 3: 757-763.
12. Morvan JM, Boisier P, Andrianimanana D, Razainirina J, Rakoto-Andiranarivelo M, Roux JF. Serological markers of hepatitis A, B, and C in Madagascar: first survey in a rural zone [in French]. Bull Soc Pathol Exot 1994; 87: 138-142.
13. Ndumbe PM, Njie TK. Hepatitis A and B infections in Yaounde, Cameroon. Res Virol 1989; 140: 253-261.
14. Prince AM, Brotman B, Richardson L, White T, Pollock N, Riddle J. Incidence of hepatitis A virus (HAV) infection in rural Liberia. J Med Virol 1985; 15: 421-428.
15. Sathar MA, Soni PN, Fernandes-Costa FJTD, Wittenberg DF, Simjee AE. Racial differences in the seroprevalence of hepatitis A virus infection in Natal/Kwazulu, South Africa. J Med Virol 1994; 44: 9-12.
16. Schwarz TF, Kam CC, Min GL, et al. Prevalence of antibodies against hepatitis A virus, hepatitis B virus, and Treponema pallidum in Mauritius. Scand J Infect Dis 1991; 23: 535-541.
17. Shaw Jr. FE. Hadler SC, Maynard JE, Konfortion P, Law-Min G, Brissonette G, Ramphul J. Hepatitis A in Mauritius: an apparent transition from endemic to epidemic transmission patterns. Ann Trop Med Parasitol 1989; 83: 179-185.
18. Song E, Kew MC. The seroepidemiology of hepatitis A virus infection in South African Chinese people. J Viral Hepat 1994; 1: 149-153.
19. Steele AD, Bos P, Joubert JJ, Bafort JM, Lecatsas G, Aspinall S. Serologic markers for hepatitis B virus and hepatitis A virus in Bushmen in West Caprivi, Namibia. East Afr Med J 1995; 72: 30-32.
20. Stroffolini T, Chiaramonte M, Ngatchu T, et al. A high degree of exposure to hepatitis A virus infection in urban children in Cameroon. Microbiológica 1991; 14: 199-203.
21. Taylor MB, Cox N, Very MA, Grabow WOK. The occurrence of hepatitis A and astroviruses in selected river and dam waters in South Africa. Water Res 2001; 35: 2653-2660.
22. Tsega E, Nordenfelt E, Mengesha B, Hansson BG, Tsega M, Lindberg J. Age-specific prevalence of hepatitis A virus antibody in Ethiopian children. Scand J Infect Dis 1990; 22: 145-148.
23. Wankya BM, Hansen DP, Ngindu AMN, Feinstone SF, Purcell RH. Seroepidemiology of hepatitis A and B in Kenya: a rural population survey in Machakos District. East Afr Med J 1979; 56: 134-138.
24. Werner GT, Frösner GG, Fresenius K. Prevalence of serological hepatitis A and B markers in a rural area of Northern Zaire. Am J Trop Med Hyg 1985; 34: 620-624.
25. White GF, Bradley DJ, White AU. Drawers of water: domestic water use in East Africa. Chicago: University of Chicago Press, 1972.
26. Willcox M, Brohult J, Olsson I, Bengtsson E. Antibody to hepatitis A virus in Liberians. Trans R Soc Trop Med Hyg 1980; 74: 690.
27. Alameida LM, Amaku M, Azevedo RS, Cairncross S, Massad E. The intensity of transmission of hepatitis A and heterogeneities in social-environmental risk factors in Rio de Janeiro, Brazil. Trans R Soc Trop Med Hyg 2002; 96: 605-610.
28. Alameida LM, Werneck GL, Cairncross S, Coeli CM, Costa MCE, Coletty PE. The epidemiology of hepatitis A in Rio de Janeiro: environmental and domestic risk factors. Epidemiol Infect 2001; 107 327-333.
29. Amesty-Valbuena A, Gonzalea-Pirela Y, Rivero M. Seroepidemiological study of hepatitis A virus in children in Maracaibo, Venezuela [in Spanish]. Invest Clin 1989; 30: 215-228.
30. Bartoloni A, Bartalesi F, Roselli M, et al. Prevalence of antibodies against hepatitis A and E viruses among rural populations of the Chaco region, south-eastern Bolivia. Trop Med Int Health 1999; 4 596-601.
31. Batik O, Craun GF, Tuthill RW, Kraemer DF. An epidemiology study of the relationship between hepatitis A and water supply characteristics and treatment. Am J Public Health 1980; 70: 167-168.
32. Bell BP, Shapiro CN, Alter MJ, et al. The diverse patterns of hepatitis A epidemiology in the United States - implications for vaccination strategies. J Infect Dis 1998; 178: 1579-1584.
33. Bergeisen GH, Hinds MW, Skaggs JW. A waterborne outbreak of hepatitis A in Meade County, Kentucky. Am J Public Health 1985; 75: 161-164.
34. Brown MG, Lindo JF, King SD. Investigations of the epidemiology of infections with hepatitis A virus in Jamaica. Ann Trop Med Parasitol 2000; 94: 497-502.
35. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48 (no. RR-12).
36. Cherubin CE, Nair SR, Dienstag JL, Purcell RH, Szmuness W. Antibody to hepatitis A and B in children in New York City. Pediatrics 1978; 61: 781-783.
37. Clemens SA, Fonseca JC, Azevedo T, et al. Hepatitis A and hepatitis B seroprevalence in four centers in Brazil. Rev Soc Bras Med Trop 2000; 33: 1-10.
38. Craig PG, Bryan JP, Miller RE, et al. The prevalence of hepatitis A, B and C infection among different ethnic groups in Belize. Am J Trop Med Hyg 1993; 49: 430-434.
39. Crewe MD, Embil JA, Garner JB. Prevalence of antibodies to hepatitis A in Nova Scotia children. Can Med Assoc J 1983; 128: 1195-1197.
40. Das A. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Hepatology 1999; 29: 548-552.
41. Desenclos JA, MacLafferty L. Community wide outbreak of hepatitis A linked to children in day care centers and with increased transmission in young adult men in Florida 1988-9. J Epidemiol Community Health 1993; 47: 269-273.
42. Fix AD, San Martin O, Gallicchio L, Vial PA, Lagos R. Age-specific prevalence of antibodies to hepatitis A in Santiago, Chile: risk factors and shift in age of infection among children and young adults. Am J Trop Med Hyg 2002; 66: 628-632.
43. Gandolfo GM, Ferri GM, Conti L, et al. Prevalence of infections by hepatitis A, B, C and E viruses in two different socioeconomic groups from Santa Cruz, Bolivia. Med Clin (Barc) 2003; 120: 725-727.
44. Gaze R, Carvalho DM, Werneck GL. Hepatitis A and B seroprevalence in Macae, Rio de Janeiro State, Brazil. Cad Saude Publica 2002; 18: 1251-1259.
45. Hejkal TW, Keswick B, LaBelle RL, et al. Viruses in a community water supply associated with an outbreak of gastroenteritis and infectious hepatitis. J Am Water Works Assoc 1982; 74: 318-321.
46. Ibarra H, Riedemann S, Prado V, et al. Actual hepatitis A virus immunity states in diverse groups of adults [in Spanish]. Rev Med Chil 1999; 127: 1165-1168.
47. Ibarra H, Riedemann S, Reinhardt G, Hochstein-Mintzel V, Frösner G. Antibodies to hepatitis A: prevalence in children in two rural areas of Chile [in Spanish]. Rev Med Chil 1988; 116: 1115-1118.
48. Jin A, Martin JD. Hepatitis A among residents of first nations reserves in British Columbia, 1991-1996. Can J Public Health 2003; 94: 176-179.
49. Kilpatrick ME, Escamilla J. Hepatitis A in Peru: the role of children. Am J Epidemiol 1986; 124: 111-113.
50. Koff RS. Seroepidemiology of hepatitis A in the United States. J Infect Dis 1995; 171: S19-23.
51. Kumate J, Alvizouri AM, Isibasi A. Serologic survey of hepatitis A antibodies in Mexican children. Bull Pan Am Health Organ 1982; 16: 156-160.
52. Leach CT, Koo FC, Hilsenbeck SG, Jenson HB. The epidemiology of viral hepatitis in children in south Texas: increase in prevalence of hepatitis A along the Texas-Mexico border. J Infect Dis 1999; 180: 509-513.
53. Levy I, Chen D, Sherman M, Smith D, Krajden M. Hepatitis A virus seroprevalence in 1,000 university students in Toronto. Can Commun Dis Rep 2001; 27: 93-96.
54. Lippy EC, Waltrip SC. Waterborne disease outbreaks - 1946-1980: a thirty-five-year perspective. J Am Water Works Assoc 1984; 76: 60-67.
55. López H, Zitto T, Baré P, Vidal G, Vukasovic J, Gómez R. Prevalence of anti-hepatitis A antibodies in an urban middle class area of Argentina: some associated factors. Int J Infect Dis 2000; 4: 34-37.
56. Luiz RR, Almeida RM, Almeida RT, de Almeida LM. The relation between anti-hepatitis A virus antibodies and residence water access in Rio de Janeiro, Brazil. Int J Hyg Environ Health 2003; 206: 575-582.
57. Maynard JE, Bradley DW, Hornbeck CL, Fields RM, Doto IL, Hollinger FB. Preliminary serologic studies of antibody to hepatitis A virus in populations in the United States. J Infect Dis 1976; 134: 528-530.
58. Minuk GY, Waggoner JG, Jernigan R, Nicolle LE, Postl B, Hoofnagle JH. Prevalence of antibody to hepatitis A virus in a Canadian Inuit community. Can Med Assoc J 1982; 127: 850-852.
59. Montano DA, Baranano R, Legeard B, et al. Prevalence of hepatitis A in children aged 2 to 14 and the working population aged 18 to 49 in Montevideo, Uruguay [in Spanish]. Rev Med Uruguay 2001; 17 84-98.
60. Mosley JW. Water-borne infectious hepatitis (pt 2). N Engl J Med 1959; 261: 748-753.
61. Nath N, Mazzur S, Fang C, et al. Prevalence of antibodies to hepatitis A virus (HAV) in blood donors of 13 western hemisphere countries and territories. Bull Pan Am Health Organ 1980; 14: 135-138.
62. Ochnio JJ, Scheifele DW, Ho M. Hepatitis A in urban children: are preventive opportunities being missed? J Infect Dis 1997; 176: 1610-1613.
63. O'Connor JB, Imperiale TF, Singer ME. Cost-effectiveness of hepatitis A vaccination strategies for adults. Hepatology 1999; 30: 1077-1081.
64. Pannuti CS, de Mendonca JS, Carvalho MJ, Oselka GW, Amato Neto V. Hepatitis A antibodies in two socioeconomically distinct populations of Sao Paulo, Brazil. Rev Inst Med Trop São Paulo 1985; 27: 162-164.
65. Payment P. Antibody levels to selected enteric viruses in a French-Canadian population in the province of Quebec (Canada). Immunol Infect Dis 1991; 1: 317-322.
66. Pérez OM, Morales W, Paniagua M, Strannegard O. Prevalence of antibodies to hepatitis A, B, C, and E viruses in a healthy population in Leon, Nicaragua. Am J Trop Med Hyg 1996; 55: 17-21.
67. Pinho JRR, Sumita LM, Moreira RC, et al. Duality of patterns in hepatitis A epidemiology: a study involving two socioeconomically distinct populations in Campinas, São Paulo State, Brazil. Rev Inst Med Trop Sao Paulo 1998; 40: 105-106.
68. Quieroz DA, Cardoso DD, Martelli CM, et al. Risk factors and prevalence of antibodies against hepatitis A virus (HAV) in children from day-care centers in Goiania, Brazil. Rev Inst Med Trop Sao Paulo 1995; 37: 427-433.
69. Redlinger T, O'Rourke K, VanDerslice J. Hepatitis A among schoolchildren in a US-Mexico border community. Am J Public Health 1997; 87: 1715-1717.
70. Riedemann S, Ibarra H, Reinhardt G, Frösner G, Safary A. Prevalence of antibodies against hepatitis A virus in Chilean school age children. Rev Med Chil 1998; 126: 1161-1164.
71. Rosenthal P. Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults. Hepatology 2003; 37: 44-51.
72. Saab S, Martin P, Yee HF. A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination. Am J Med 2000; 109: 241-244.
73. Saback FL, Palmer TE, Sabino RR, et al. Infection with hepatitis A and TT viruses and socioeconomic status in Rio de Janeiro, Brazil. Scand J Infect Dis 2001; 33: 121-125.
74. Santos DCM, Souto FJD, Santos DRL, Vitral CL, Gaspar AMC. Seroepidemiological markers of enterically transmitted viral hepatitis A and E in individuals living in a community located in the north are of Rio de Janeiro, RJ, Brazil. Mem Inst Oswaldo Cruz 2002; 97: 637-640.
75. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: sero-epidemiology and risk groups in the USA. Vaccine 1992; 10: S59-S62.
76. Steinberg EB, Mendoza CE, Glass R, et al. Prevalence of infection with waterborne pathogens: a sero-epidemiologic study in children 6-36 months old in San Juan Sacatepequez, Guatemala. Am J Trop Med Hyg 2004; 70: 83-88.
77. Stevens CE, Cherubin CE, Dienstag JL, Purcell RH, Szmuness W. Antibody to hepatitis A antigen in children. J Pediatr 1977; 91: 436-438.
78. Struchiner CJ, de Almeida LM, de Azevedo RS, Massad E. Hepatitis A incidence rate estimates from a pilot seroprevalence survey in Rio de Janeiro, Brazil. Int J Epidemiol 1999; 28: 776-781.
79. Szmuness W, Dienstag JL, Purcell RH, Harley EJ, Stevens CE, Wong DC. Distribution of antibody to hepatitis A antigen in urban adult populations. N Engl J Med 1976; 295: 755-759.
80. Tapia-Conyer R, Santos JI, Cavalcanti AM, et al. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg 1999; 61: 825-829.
81. Taylor FB, Eagen JH, Smith HFD, Coene RF. The case for water-borne infectious hepatitis. Am J Public Health 1966; 56: 2093-2105.
82. Villar LM, De Paula VS, Gaspar AM. Seasonal variation of hepatitis A virus infection in the city of Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo 2002; 44: 289-292.
83. Villarejos VM, Provost PJ, Ittensohn OL, McLean AA, Hilleman MR. Seroepidemiologic investigations of human hepatitis caused by A, B, and a possible third virus. Proc Soc Exp Biol Med 1976; 152: 524-528.
84. Villarejos VM, Serra CJ, Anderson-Visona K, Mosley JW. Hepatitis A virus infection in households. Am J Epidemiol 1982; 115 577-586.
85. Vitral CL, Yoshida CFT, Lemos ERS, Teixeira CS, Gaspar AMC. Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995: relationship of prevalence to environmental factors. Mem Inst Oswaldo Cruz 1997; 93 1-5.
86. Vogt JE. Infectious hepatitis epidemic at Posen, Michigan. J Am Water Works Assoc 1961; 53: 1238-1242.
87. Zacarías J, Rakela J, Macho L, Mosley J. Study of hepatitis A antibodies in children [in Spanish]. Boletín Mé dico del Hospital Infantil de México 1979; 36: 571-579.
88. Zacarías J, Rakela J, Riveros C, Brinck P. Hepatitis A antibodies: prevalence in apparently healthy children and with acute hepatitis [in Spanish]. Rev Med Chil 1981; 109: 833-836.
89. Agboatwalla M, Isomura S, Miyake K, Yamashita T, Morishita T, Akram DS. Hepatitis A, B and C seroprevalence in Pakistan. Indian J Pediatr 1994; 61: 545-549.
90. Al-Ghamdi A, Bales JD. Hepatitis A in eastern Saudi Arabia. Saudi Med J 1984; 5: 303-306.
91. Al Rashed R. Prevalence of hepatitis A virus among Saudi Arabian children: a community-based study. Ann Saudi Med 1997; 17: 200-203.
92. Antaki N, Kamel Kebbewar M. Hepatitis A seroprevalence rate in Syria. Trop Doct 2000; 30: 99-101.
93. Baki A, Aynaci M, Koksal I. Prevalence of antibody to hepatitis A virus among children in Trabzon, Turkey. Infection 1993; 21: 132-133.
94. Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am J Trop Med Hyg 1996; 54: 554-558.
95. El-Hamzi MAF. Hepatitis A antibodies: prevalence in Saudi Arabia. J Trop Med Hyg 1989; 92: 427-430.
96. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian populations: a viral marker study. Ann Acad Med Singapore 1980; 9: 144-148.
97. Fathalla SE, Al-Jama AA, Al-Sheikh IH, Islam SI. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia. Saudi Med J 2000; 21: 945-949.
98. Gdalevich M, Grotto I, Mandel Y, Mimouni D, Shemer J, Ashkenazi I. Hepatitis A antibody prevalence among young adults in Israel: the decline continues. Epidemiol Infect 1998; 121: 477-479.
99. Green MS, Cohen D, Slepon R, et al. Socio-demographic correlates of neutralizing poliovirus and hepatitis A virus antibodies as markers of different modes of acquiring immunity. Am J Public Health 1990; 80: 1270-1271.
100. Green MS, Tsur S, Slepon R. Sociodemographic factors and the declining prevalence of anti-hepatitis A antibodies in young adults in Israel: implications for the new hepatitis A vaccines. Int J Epidemiol 1992; 21: 136-141.
101. Green MS, Zaaide Y. Sibship size as a risk factor for hepatitis A infection. Am J Epidemiol 1989; 129: 800-805.
102. Kanra G, Tezcan S, Badur S. Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr 2002; 44: 204-210.
103. Khalfa S, Ardjoun H. Epidemiology of viral hepatitis in Algeria [in French]. Med Trop 1984; 44: 247-252.
104. Khalil M, Al-Mazrou Y, Al-Jeffri M, Al-Howasi M. Childhood epidemiology of hepatitis A virus in Riyadh, Saudi Arabia. Ann Saudi Med 1998; 18: 18-21.
105. Nejmi S, Coursaget P, D'Khissy D, Barres JL, Chiron P. Prevalence of hepatitis A and B viral infections in Morocco [in French]. Presse Med 1984; 13: 1786-1787.
106. Ramia S. Antibody against hepatitis A in Saudi Arabians and in expatriates from various parts of the world working in Saudi Arabia. J Infect 1986; 12: 153-155.
107. Scott DA, Burans JP, al-Ouzeib HD, et al. A sero-epidemiological survey of viral hepatitis in the Yemen Arab Republic. Trans R Soc Trop Med Hyg 1990; 84: 288-291.
108. Shamma'a MH, Abu-Samra S, Salameh V, Nassar NT. The significance of anti-HAV in different population sectors in Lebanon: a comparative sero-epidemiologic study. Int J Epidemiol 1982; 11: 406-409.
109. Shobokshi O, Serebour F, Abdul-Rahim SM. The prevalence and pattern of hepatitis A viral infection in the western region of Saudi Arabia. Saudi Med J 1986; 7: 402-408.
110. Sidal M, Unuvar E, Oguz F, Cihan C, Onel D, Badur S. Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey. Eur J Epidemiol 2001; 17: 141-144.
111. Toukan AU, Sharaiha ZK, Abu-el-Rob OA, et al. The seroepidemiology of hepatitis A virus infection in Jordan. Trop Gastroenterol 1988; 9: 76-79.
112. Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine 2000; 18: S65-S67.
113. Ungan M, Yaman H, Taheri N. The seroprevalence of specific antibodies to hepatitis A virus in a Turkish population. Eur J Gastroenterol Hepatol 2002; 14: 1033-1034.
114. Yapicioglu H, Alhan E, Yildizdas D, Yaman A, Bozdemir N. Prevalence of hepatitis A in children and adolescents in Adana, Turkey. Indian Pediatr 2002; 39: 936-941.
115. Amela C, Pachón I, Bueno R, de Miguel C, Martinez-Navarro F. Trends in hepatitis A virus infection with reference to the process of urbanization in the greater Madrid area (Spain). Eur J Epidemol 1995; 11: 569-573.
116. Barros H, Oliveira F, Miranda H. A survey on hepatitis A in Portuguese children and adolescents. J Viral Hepat 1999; 6: 249-253.
117. Beran J, Douda P, Rychly R. Seroprevalence of viral hepatitis A in the Czech Republic. Eur J Epidemiol 1999; 15: 805-808.
118. Bernal W, Smith HM, Williams R. A community prevalence study of antibodies to hepatitis A and E in inner-city London. J Med Virol 1996; 49: 230-234.
119. Beutels M, Van Damme P, Aelvoet W, et al. Prevalence of hepatitis A, B and C in the Flemish population. Eur J Epidemiol 1997; 13: 275-280.
120. Bolumar F, Giner-Duran R, Hernandez-Aguado I, Serra-Desfilis MA, Rebagliato M, Rodrigo JM. Epidemiology of hepatitis A in Valencia, Spain: public health implications. J Viral Hepat 1995; 2: 145-149.
121. Böttiger M, Christenson B, Grillner L. Hepatitis A immunity in the Swedish population: a study of the prevalence of markers in the Swedish population. Scand J Infect Dis 1997; 29: 99-102.
122. Briem H. Declining prevalence of antibodies to hepatitis A virus infection in Iceland. Scand J Infect Dis 1991; 23: 135-138.
123. Briem H, Weiland O, Frioriksson I, Berg R. Prevalence of antibody to hepatitis A in Iceland in relation to age, sex, and number of notified cases of hepatitis. Am J Epidemiol 1982; 116: 451-455.
124. Bruguera M, Salleras L, Plans P, et al. Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996: implications for new vaccination strategy. Med Clin (Barc) 1999; 112: 406-408.
125. Castelli F, Carosi G, Tebaldi A, et al. Age-specific anti-hepatitis A virus seroepidemiology in Italian travelers: indications for anti-hepatitis A vaccination. J Travel Med 1996; 3: 214-218.
126. Chiaramonte M, Moschen ME, Stroffolini T, et al. Changing epidemiology of hepatitis A virus (HAV) infection: a comparative seroepidemiological study (1979 vs 1989) in north-east Italy. Italian J Gastroenterol 1991; 23: 344-346.
127. Cianciara J. Hepatitis A shifting epidemiology in Poland and Eastern Europe. Vaccine 2000; 18: S68-S70.
128. Dal-Ré R, Aguilar L, Coronel P. Current prevalence of hepatitis B, A and C in a healthy Spanish population. Infection 1991; 19: 409-413.
129. Dal-Ré R, García-Corbeira P, García-de-Lomas J. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A. J Med Virol 2000; 6: 363-366.
130. Dalekos GN, Zervou E, Karabini F, Tsianos EV. Prevalence of viral markers among refugees from southern Albania: increased incidence of infection with hepatitis A, B and D viruses. Eur J Gastroenterol Hepatol 1995; 7: 553-558.
131. Damjanovic V, Ross M, Brumfitt W. Studies on antibody to hepatitis A virus in children and adults in London. Infection 1979; 7 267-272.
132. D'Argenio P, Esposito D, Mele A, et al. Decline in the exposure to hepatitis A and B virus infection in children in Naples, Italy. Public Health 1989; 103: 385-389.
133. Denis F, Delpeyroux C, Debrock C, Rogez S, Alain S. Scroprevalence of hepatitis A in hospitalized patients in Limoges University Hospital. Gastroenterol Clin Biol 2003; 27: 727-731.
134. Errezola Saizar M. Epidemiological study of a water-borne outbreak of hepatitis A [in Spanish]. Med Clin (Barc) 1983; 80: 389-393.
135. Franco E, Vitiello G. Vaccination strategies against hepatitis A in southern Europe. Vaccine 2003; 21: 696-697.
136. Frösner GG, Papaevangelou G, Bütler R, et al. Antibody against hepatitis A in seven European countries. I: comparison of prevalence data in different age groups. Am J Epidemiol 1979; 110: 63-69.
137. Frösner G, Willers H, Müller R, Schenzle D, Deinhardt F, Höpken W. Decrease in incidence of hepatitis A infections in Germany. Infection 1978; 6: 259-260.
138. Garcia-Fulgueiras A, Rodriguez T, Tormo MJ, Perez-Flores D, Chirlaque D, Navarro C. Prevalence of hepatitis A antibodies in southeastern Spain: a population-based study. Eur J Epidemiol 1997; 13 481-483.
139. Gay NJ, Morgan-Capner P, Wright J, Farrington CP, Miller E. Age-specific antibody prevalence to hepatitis A in England: implications for disease control. Epidemiol Infect 1994; 113: 113-120.
140. González A, Bruguera M, Calbo Torrecillas F, Monge V, Dal-Ré R, Costa J. Serological inquiry of antihepatitis A antibody prevalence in the Spanish young adult population [in Spanish]. Med Clin (Barc) 1994; 103: 445-448.
141. Grzeszczuk A, Sokolewicz-Bobrowska E, Chlabicz S. Occupational risk of hepatitis A infection among health care providers in northeastern Poland. Med Sci Monit 2003; 9: PH11-14.
142. Gudkov VG, Tomal LS, Rytik PG, Shket VA, Moroz AG. Status of collective immunity to hepatitis A virus in urban residents in Byelorussia. Zh Mikrobiol Epidemiol Immunobiol 1992; 3: 60-62.
143. Higgins G, Wreghitt TG, Gray JJ, Blagdon J, Taylor CED. Hepatitis A antibody in East Anglian blood donors. Lancet 1990; 336 1330.
144. Iwarson S, Frösner G, Lindholm A, Norkrans G. The changed epidemiology of hepatitis A infection in Scandinavia. Scand J Infect Dis 1978; 10: 155-156.
145. Kornachev AS, Mikhailova NB, Dubrovskaia LR, Sitkov VI. The determination of hepatitis A antibodies in epidemiological practice. Zh Mikrobiol Epidemiol Immunobiol 1990; 4: 59-60.
146. Kremastinou J, Kalapothaki V, Trichopoulos D. The changing epidemiologic pattern of hepatitis A infection in urban Greece. Am J Epidemiol 1984; 120: 703-706.
147. La Rosa G, Guli V, Terrana B. First results of anti HAV antibodies assay in Western Sicily. Boll Ist Sieroterapico Milan 1978; 57: 682-683.
148. Lagarde E, Joussemet M, Lataillade JJ, Fabre G. Risk factors for hepatitis A infection in France: drinking tap water may be of importance. Eur J Epidemiol 1995; 11: 145-148.
149. Langer BCA, Frösner GG, von Brunn A. Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland. J Viral Hepat 1997; 4: 339-349.
150. Lecour H, Ribeiro AT, Amaral I, Rodrigues MA. Prevalence of viral hepatitis in the population of Portugal. Bull World Health Organ 1984; 62: 743-747.
151. Linneberg A, Østergaard C, Tvede M, et al. IgG antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen Allergy Study. J Allergy Clin Immunol 2003; 111: 847-853.
152. Lionis C, Koulentaki M, Biziagos E, Kouroumalis E. Current prevalence of hepatitis A, B and C in a well-defined area in rural Crete, Greece. J Viral Hepat 1997; 4: 55-61.
153. Macedo G, Ribeiro T. Hepatitis A: insights into new trends in epidemiology. Eur J Gastroenterol Hepatol 1998; 10: 175.
154. Marinho RT, Valente AR, Ramalho FJ, de Moura MC. The changing epidemiological pattern of hepatitis A in Lisbon, Portugal. Eur J Gastroenterol Hepatol 1997; 9: 795-797.
155. Mathiesen LR, Skinhøj P, Balstrup F. Antibody to hepatitis A virus in plasma of Danish blood donors and in immune serum globulin produced in Denmark. Scand J Infect Dis 1980; 12: 81-83.
156. Mele A, Stroffolini T, Palumbo F, et al. Incidence of risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. J Hepatol 1997; 26: 743-747.
157. Montes I, Agulla A. Prevalencia de marcadores de hepatitis viricas en niños del norte de Extremadura. Anales de Pediatria 1996; 45: 133-136.
158. Morales JL, Huber L, Gallego S, et al. A seroepidemiologic study of hepatitis A in Spanish children: relationship of prevalence of age and socioeconomic factors. Infection 1992; 20: 194-196.
159. Morris MC, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. The changing epidemiological pattern of hepatitis A in England and Wales. Epidemiol Infect 2002; 128: 457-463.
160. Moschen ME, Floreani A, Zamparo E, et al. Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy. Eur J Epidemiol 1997; 13: 875-878.
161. Paquet C, Babes VT, Drucker J, Senemaud B, Dobrescu A. Viral hepatitis in Bucharest. Bull World Health Organ 1993; 71: 781-786.
162. Pasquini P, Kahn HA, Pileggi D, Pana A, Terzi I, D'Arca I. Prevalence of hepatitis A antibodies in Italy. Int J Epidemiol 1984; 13: 83-86.
163. Péchevis M, Khoshnood B, Buteau L, Durand I, Piquard Y, Lafuma A. Cost-effectiveness of hepatitis A vaccine in prevention of secondary hepatitis A infection. Vaccine 2003; 21: 3556-3564.
164. Perez-Trallero E, Cilla G, Urbieta M, Dorronsoro M, Otero F, Marimon JM. Falling incidence and prevalence of hepatitis A in northern Spain. Scand J Infect Dis 1994; 26: 133-136.
165. Pohl O, Brojnás J, Rusvai E, et al. Retrospective detection of a subclinical hepatitis A virus (HAV) epidemic affecting juvenile cohorts of the Hungarian population. FEMS Immunol Med Microbiol 2003; 38: 85-91.
166. Polz-Dacewicz MA, Policzkiewicz P, Badach Z. Changing epidemiology of hepatitis A virus infection: a comparative study in Central Eastern Poland (1990-1999). Med Sci Monit 2000; 6: 989-993.
167. Prodinger WM, Larcher C, Solder BM, Geissler D, Dietrich MP. Hepatitis A in western Austria: the epidemiologic situation before the introduction of active immunisation. Infection 1994; 22: 53-55.
168. Rajan E, O'Farrell B, Shattock AG, Fielding JF. Hepatitis A in urban Ireland. Ir J Med Sci 1998; 167: 231-233.
169. Rodriguez-Iglesias MA, Perez-Garcia MT, Garcia-Valdivia MS, Perez-Ramos S. Seroprevalence of hepatitis A virus antibodies in a pediatric population of southern Spain. Infection 1995; 23: 309.
170. Rooney PJ, Coyle PV. The role of herd immunity in an epidemic cycle of hepatitis A. J Infect 1992; 24: 327-331.
171. Rubió PP. Critical value of prevalence for vaccination programmes: the case of hepatitis A vaccination in Spain. Vaccine 1997; 15: 1445-1450.
172. Salleras L, Bruguera M, Vidal J, et al. A change in the epidemiologic pattern of hepatitis A in Spain. Med Clin (Barc) 1992; 99: 87-89.
173. Santantonio T, Lo Caputo S, Germinario C, et al. Prevalence of hepatitis virus infections in Albanian refugees. Eur J Epidemiol 1993; 9: 537-540.
174. Shliakhtenko LI, Kryga LN, Aleinik MD, et al. The morbidity and immunological structure of the population in viral hepatitis A at different phases in the development of multiyear epidemic cycles. Zh Mikrobiol Epidemiol Immunobiol 1994; 5: 42-45.
175. Siebke JC, Degre M, Ritland S, Enger SC. Prevalence of hepatitis A antibodies in a normal population and some selected groups of patients in Norway. Am J Epidemiol 1982; 115: 185-191.
176. Sočan M, Kraigher A, Fišer-Marinič N. Hepatitis A seroprevalence in Slovene travellers. Eur J Epidemiol 2001; 17: 925-926.
177. Stroffolini T, Chiaramonte M, Franco E, et al. Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy. Infection 1991; 19: 97-100.
178. Stroffolini T, De Crescenzo L, Giammanco A, et al. Changing pattern of hepatitis A infection in children in Palermo, Italy. Eur J Epidemiol 1990; 6: 84-87.
179. Stroffolini T, Pretolani S, Miglio F, et al. Population-based survey of hepatitis A virus infection in the Republic of San Marino. Eur J Epidemiol 1997; 13: 687-689.
180. Szmuness W, Dienstag JL, Purcell RH, et al. The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol 1977; 106: 392-398.
181. Termorshuizen F, Dorigo-Zetsma JW, de Melker HE, van den Hof S, Conyn-Van Spaendonck MAE. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey. Epidemiol Infect 2000; 134: 459-466.
182. Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R. Prevalence of markers for hepatitis A, B and C in the German population: results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 2001; 17: 429-435.
183. Trevisan A, Stocco E, Fanelli G, Bicciato F, Paruzzolo P. Seroprevalence of hepatitis A markers in subjects exposed to biological risk. Int Arch Occup Environ Health 1999; 72: 125-127.
184. Ukkonen P, Petterson R, Halonen P. Hepatitis A antibodies in Finland. Scand J Infect Dis 1979; 11: 311-312.
185. Vargas V, Buti M, Hernandez-Sanchez JM, et al. Prevalence of antibodies against hepatitis A virus in the general population: a comparative study 1977-85 [in Spanish]. Med Clin (Barc) 1987; 88: 144-146.
186. Vranckx R, Muylle L. Hepatitis A virus antibodies in Belgium: relationship between prevalence and age. Infection 1990; 18: 364-366.
187. Webster G, Barnes E, Dusheiko G, Franklin I. Protecting travellers from hepatitis A. Br Med J 2001; 322: 1194-1195.
188. Weiland O, Berg R, Böttiger M, Lundberge P. Prevalence of antibody against hepatitis A in Sweden in relation to age and type of
189. Zanetti AR, Ferroni P, Bastia A. Decline in incidence of hepatitis A infection in Milan: a serologic study. Boll Ist Sieroterapico Milan 1978; 57: 816-820.
190. Zanetti AR, Romano L, Tanzi E, et al. Decline in anti-HAV prevalence in the Milan area between 1958-1992. Eur J Epidemiol 1994; 10: 633-635.
191. Acharya SK, Batra Y, Bhatkal B, et al. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. J Gastroenterol Hepatol 2003; 18: 822-827.
192. Aggarwal R, Naik S, Yachha SK, Naik SR. Seroprevalence of antibodies to hepatitis A virus among children in northern India. Indian Pediatr 1999; 36: 1248-1250.
193. Arankalle VA, Chadha MS, Chitambar SD, Walimbe AM, Chobe LP, Gandhe SS. Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-1998). J Viral Hepat 2001; 8: 293-303.
194. Arankalle VA, Tsarev SA, Chadha MS, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995; 171: 447-450.
195. Batra Y, Bhatkal B, Ojha B, et al. Vaccination against hepatitis A virus may not be required for school-children in northern India: results of a seroepidemiological survey. Bull World Health Organ 2002; 80: 728-731.
196. Brown P, Greguer G, Smallwood L, Nevy R, Moerdowo RM, Gerety RJ. Serologic markers of hepatitis A and B in the population of Bali, Indonesia. Am J Trop Med Hyg 1985; 34: 616-619.
197. Burke DS, Snitbhan R, Johnson DE, Scott R McN. Age specific prevalence of hepatitis A virus antibody in Thailand. Am J Epidemiol 1981; 113: 245-249.
198. Chitambar SD, Chadha MS, Joshi MS, Arankalle VA. Prevalence of hepatitis A antibodies in western Indian population: changing pattern. Southeast Asian J Trop Med Public Health 1999; 30: 273-276.
199. Corwin AL, Jarot K, Lubis I, et al. Two years investigation of epidemic hepatitis E virus transmission in West Kalimantan (Borneo) Indonesia. Trans R Soc Trop Med Hyg 1995; 89: 262-265.
200. Corwin AL, Putri MP, Winarno J, et al. Epidemic and sporadic hepatitis E virus transmission: West Kalimantan (Borneo), Indonesia. Am J Trop Med Hyg 1997; 57: 62-65.
201. Da Villa G, Andjaparidze A, Cauletti M, et al. Viral hepatitis in the Bhutanese population: preliminary results of a seroepidemiological investigation. Res Virol 1997; 148: 115-117.
202. Das K. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol 2000; 16: 507-510.
203. Dhawan PS, Shah SS, Alvares JF, et al. Seroprevalence of hepatitis A in Mumbai, and immunogenicity and safety of hepatitis A vaccine. Indian J Gastroenterol 1998; 17: 16-18.
204. Dutta AK, Aggarwal A, Kapoor AK, Ray GN, Batra S. Seroepidemiology of hepatitis A in Delhi. Indian J Pediatr 2000; 67 77-79.
205. Echeverria P, Burke DS, Blacklow NR, Cukor G, Charoenkul C, Yanggratoke S. Age-specific prevalence of antibody to rotavirus, Escherichia coli heat-labile enterotoxin, Norwalk virus, and hepatitis A virus in a rural community in Thailand. J Clin Microbiol 1983; 17 923-925.
206. Gandi BM, Joshi YK, Tandon BN. Prevalence of virus A exposure and viral hepatitis A in India. Lancet 1981; 2: 374.
207. Innis N, Snitbhan R, Hoke CH, Munnindhorn W, Laorakpongse T. The declining transmission of hepatitis A in Thailand. J Infect Dis 1991; 163: 989-995.
208. Juffrie M, Graham RR, Tan RI, et al. Seroprevalence of hepatitis A virus and varicella zoster antibodies in Javanese community (Yogyakarta, Indonesia). Southeast Asian J Trop Med Public Health 2000; 31: 21-24.
209. Jutavijittum P, Jiviriyawat Y, Jiviriyawat W, Yousukh A, Hayashi S, Toriyama K. Present epidemiological pattern of antibody to hepatitis A virus among Chiang Mai children, northern Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 268-271.
210. Kalayanarooj S, Vaughn DW, Snitbhan R, Ariyasriwatana C. Age-specific prevalence of hepatitis A antibody in Thai children. Southeast Asian J Trop Med Public Health 1995; 26: 709-711.
211. Kosuwan P, Sutra S, Kosalaraksa P, Poovorawan Y. Seroepidemiology of hepatitis A virus antibody in primary school children in Khon Kaen Province, northeastern Thailand. Southeast Asian J Trop Med Public Health 1996; 27: 650-653.
212. Kunasol P, Cooksley G, Chan VF, et al. Hepatitis A virus: declining seroprevalence in children and adolescents in southeast Asia. Southeast Asian J Trop Med Public Health 1998; 29: 255-262.
213. Luksamijarulkul P, Pumsuwan V, Pungchitton S. Microbiological quality of drinking water and using water of a Chao Phya River community, Bangkok. Southeast Asian J Trop Med Public Health 1994; 25: 633-637.
214. Mall ML, Rai RR, Philip M, et al. Seroepidemiology of hepatitis A infection in India: changing pattern. Indian J Gastroenterol 2001; 20: 132-135.
215. Mertens TE, Fernando MA, Marshall TF, Kirkwood BR, Cairncross S, Radalowicz A. Determinants of water quality, availability and use in Kurunegala, Sri Lanka. Trop Med Parasitol 1990; 41: 89-97.
216. Mittal SK, Rastogi A, Rastogi A, Kuman N, Talukdar B, Kar P. Seroprevalence of hepatitis A in children - implications for hepatitis A vaccine. Trop Gastroenterol 1998; 19: 120-121.
217. Mohanavalli B, Dhevahi E, Menon T, Malathi S, Thyagarajan SP. Prevalence of antibodies to hepatitis A and hepatitis E virus in urban school children in Chermai. Indian Pediatr 2003; 40: 328-331.
218. Moritsugu Y, Miyamura K, Utagawa E, Kono R, de la Motte PU, Forbes CAL. Prevalence of antibody to hepatitis A virus in Sri Lanka. Asian J Infect Dis 1979; 3: 33-36.
219. Poovorawan Y, Paiboonkasemsuthi S, Theamboonlers A, Kamolratanakul P, Chumdermpadetsuk S. Seroepidemiology of antibody to hepatitis A in the rural eastern part of Thailand. Southeast Asian J Trop Med Public Health 1991; 22: 35-38.
220. Poovorawan Y, Theamboonlers A, Chumdermpadetsuk S. Changing seroepidemiology of hepatitis A virus infection in Thailand. Southeast Asian J Trop Med Public Health 1993; 24: 250-254.
221. Poovorawan Y, Vimolkej T, Chongsrisawat V, Theamboonlers A, Chumdermpadetsuk S. The declining pattern of seroepidemiology of hepatitis A virus infection among adolescents in Bangkok, Thailand. Southeast Asian J Trop Med Public Health 1997; 28: 154-157.
222. Sawayama Y, Hayashi J, Ariyama I, et al. A ten year serological survey of hepatitis A, B and C viruses infections in Nepal. J Epidemiol 1999; 9: 350-354.
223. Sohn YM, Rho HO, Park MS, et al. The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea. Yonsei Med J 2000; 41: 34-39.
224. Tandon BN, Gandhi BM, Joshi YK. Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in north India. Bull World Health Organ 1984; 62: 67-73.
225. Teppakdee A, Tangwitoon A, Khemasuwan D, et al. Cost-benefit analysis of hepatitis A vaccination in Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 118-127.
226. Viranuvatti V, Hemindra P, Chainuvati T. Anti-HAV in Thai population. J Med Assoc Thai 1982; 65: 379-382.
227. Vitarana T, Kanapathipillai M, Gunasekera HDN, Lehmann NI, Dimitrikakis M, Gust ID. A seroepidemiological study of hepatitis A and hepatitis B infection in Sri Lanka. Asian J Infect Dis 1978; 2: 247-252.
228. Amin J, Gilbert GL, Escott RG, Heath TC, Burgess MA. Hepatitis A epidemiology in Australia: national seroprevalence and notifications. Med J Aust 2001; 174: 338-341.
229. Austin FJ, Maguire T, Jennings LC, MacDiarmid RD. The prevalence of antibodies to hepatitis A and B viruses in Port Chalmers residents. NZ Med J 1982; 701: 72-73.
230. Barzaga NG. Hepatitis A shifting epidemiology in South-East Asia and China. Vaccine 2000; 18: S61-S64.
231. Boughton CR, Hawkes RA, Ferguson V. Viral hepatitis A and B: a sero-epidemiologic study of a nonhepatitic Sydney population. Med J Aust 1980; 1: 177-180.
232. Chapman BA, Burt MJ, Frampton CM, et al. The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community. NZ Med J 2000; 113: 394-396.
233. Chin KP, Lok ASF, Wong LSK, Lai CL, Wu PC. Current seroepidemiology of hepatitis A in Hong Kong. J Med Virol 1991; 34: 191-193.
234. Fock KM, Tay HH, Phua KB, et al. Seroprevalence of anti-bodies against hepatitis A (anti-HAV) in Singapore: the NFDD experience. Singapore Med J 1995; 36: 26-27.
235. Fujisawa T, Kumagai T, Akamatsu T, Kiyosawa K, Matsunaga Y. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol 1999; 94: 2094-2099.
236. Furusyo N, Hayashi J, Sawayama Y, Kawakami Y, Kishihara Y, Kashiwagi S. The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan, over a 26-year period. Am J Trop Med Hyg 1998; 59: 693-698.
237. Geng J, Xu D, Gong J, Li W. Assessing hepatitis A virus epidemic stochastic process in eight cities in China in 1990. Int J Epidemiol 1998; 27: 320-322.
238. Goh KT, Wong LY, Oon CJ, Kumarapathy S. The prevalence of antibody to hepatitis A in Singapore. Asia Pac J Public Health 1987; 1 9-11.
239. Gust ID, Lehmann NI, Dimitrakakis M. A seroepidemiologic study of infection with HAV and HBV in five Pacific islands. Am J Epidemiol 1979; 110: 237-242.
240. Gust ID, Lewis FA, Lehmann NI. Prevalence of antibody to hepatitis A and polioviruses in an unimmunized urban population. Am J Epidemiol 1978; 107: 54-56.
241. Han CH, Hien TT, Tien NT, et al. Prevalence of enteric hepatitis A and E viruses in the Mekong River delta region of Vietnam. Am J Trop Med Hyg 1999; 60: 277-280.
242. Hawkes RA, Boughton CR, Ferguson V. The seroepidemiology of hepatitis in Papua New Guinea. Am J Epidemiol 1981; 114: 554-562.
243. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Changing seroepidemiology of hepatitis A virus infection in Taiwan. J Med Virol 1985; 174: 297-301.
244. Hu M, Schenzle D, Deinhardt F, Scheid R. Epidemiology of hepatitis A and B in the Shanghai area: prevalence of serum markers. Am J Epidemiol 1984; 120: 404-413.
245. Hwang LY, Beasley RP, Yang CS, Hsu LC, Chen KP. Incidence of hepatitis A virus infection in children in Taipei, Taiwan. Intervirology 1983; 20: 149-154.
246. Ichida F, Suzuki S, Furuta S, et al. Age specific prevalence of anti HA in Japan: from multi-institutional analysis. Gastroenterologia Japonica 1981; 16: 384-388.
247. Ikematsu H, Kashiwagi S, Hayashi J, et al. A seroepidemiologic study of hepatitis A virus infections: statistical analysis of two independent cross-sectional surveys in Okinawa, Japan. Am J Epidemiol 1987; 126: 50-54.
248. Kashiwagi S, Hayashi J, Ikematsu H, et al. Prevalence of antibody to hepatitis A virus in Okinawa and Kyushu, Japan. Am J Epidemiol 1983; 117: 55-59.
249. Katelaris PH, Robertson G, Bradbury R, Tippett G, Hoa DQ, Ngu MC. Seroprevalence of hepatitis viruses in children in rural Viet Nam. Trans R Soc Trop Med Hyg 1995; 89: 487.
250. Kiyohara T, Satoh T, Yamamoto H, Totsuka A, Moritsugu Y. The latest seroepidemiological pattern of hepatitis A in Japan. Jap J Med Sci Biol 1997; 50: 123-131.
251. Lee A, Cheng F, Lau L, Lo A, Fabb WE. Changing hepatitis A epidemiology among Hong Kong Chinese adolescents: what are the implications? Public Health 1999; 113: 185-188.
252. Lehmann NI, Gust ID. Prevalence of antibody to hepatitis A virus in two populations in Victoria, Australia. Med J Aust 1977; 2 731-732.
253. Lin DB, Tsai TP, Yang CC, et al. Current seroprevalence of hepatitis A virus infection among kindergarten children and teachers in Taiwan. Southeast Asian J Trop Med Public Health 2000; 31: 25-28.
254. Lucas CR, Milne A, Hopkirk N. Kawerau revisited: hepatitis A and B seroprevalence in 1984 and 1993. N Z Med J 1994; 107: 266-268.
255. Mäusezahl D, Cheng F, Zhang SQ, Tanner M. Hepatitis A in a Chinese urban population: the spectrum of social and behavioural risk factors. Int J Epidemiol 1996; 25: 1271-1279.
256. Moritsugu Y, Tanaka T, Shikata T. A preliminary serologic study of hepatitis A virus infection in Japan. Japanese J Med Sci Biol 1978; 31: 325-338.
257. Tan DSK, Fang R, Collett D, Ooi BG. Seroepidemiologic study of hepatitis A in Malaysia. Southeast Asian J Trop Med Public Health 1986; 17: 201-204.
258. Taylor-Wiedeman J, Moritsugu Y, Miyamura K, Yamazaki S. Seroepidemiology of hepatitis A virus in Japan. Jap J Med Sci Biol 1987; 40: 119-130.
259. Tzen KT, Change MH, Tsen TJ, Lee CY, Chen DS. Hepatitis A virus infection in Taipei City in 1989. J Formos Med Assoc 1991; 90 138-140.
260. Wang LY, Cheng YW, Chou SJ, Hsieh LL, Chen CJ. Secular trend and geographical variation in hepatitis A infection and hepatitis B carrier rate among adolescents in Taiwan: an island-wide survey. J Med Virol 1993; 39: 1-5.
261. Wang SM, Liu CC, Huang YS, Yang YJ, Lei HY. Change in hepatitis A virus seroepidemiology in southern Taiwan: a large percentage of the population lack protective antibody. J Med Virol 2001; 64: 104-108.
262. Wong DC, Purcell RH, Rosen L. Prevalence of antibody to hepatitis A and hepatitis B viruses in selected populations of the South Pacific. Am J Epidemiol 1979; 110: 227-236.
263. Wu JS, Lu CF, Wu LZ, et al. Changing seroepidemiology of hepatitis A virus infection between two regions in Taiwan differing in socio-economic status. J Formos Med Assoc 1993; 92: 812-815.
264. Yap I, Guan R. Hepatitis A sero-epidemiology in Singapore: a changing pattern. Trans R Soc Trop Med Hyg 1993; 87: 22-23.
265. Arankalle VA, Chadha MS. Who should receive hepatitis A vaccine? J Viral Hepat 2003; 10: 157-158.
266. Feachem R, Burns E, Cairncross S, et al. Water, health and development: an interdisciplinary evaluation. London: Tri-Med Books Ltd, 1978.
267. Franco E, Giambi C, Ialacci R, Coppola RC, Zanetti AR. Risk groups for hepatitis A virus infection. Vaccine 2003; 21: 2224-2233.
268. World Bank. GNI per capita 2002. World Development Indicators Database, July 2003.
269. World Health Organization. Hepatitis A. WHO/CDS/CSR/EDC/2000.7.
270. World Health Organization. Hepatitis A vaccines. Wkly Epidemiol Rec 2000; 75: 38-44.
271. WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation. Global Water Supply and Sanitation Assessment 2000. Report.